Brief: Evelo Biosciences Prioritizing EDP1908 As Lead Clinical Candidate In Oncology
09/12/2020 14:05
Dec 9 (Reuters) - Evelo Biosciences Inc EVLO.O :
* EVELO BIOSCIENCES INC - PRIORITIZING EDP1908 AS LEAD
CLINICAL
CANDIDATE IN ONCOLOGY
* EVELO BIOSCIENCES INC - WILL HALT PATIENT RECRUITMENT IN
PHASE
1/2 CLINICAL TRIAL OF EDP1503 AND WILL WIND DOWN STUDY
Source text for Eikon: ID:nGNX206bTH
Further company coverage: EVLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evelo Biosciences
See all newsU.S. RESEARCH ROUNDUP- Evelo Biosciences, Nkarta, O'Reilly Automotive
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI